Log In
CQMS
Make a Donation
Log In
Donate
Sign up now for the 2025 Trek4TROG Light-to-Light Challenge
Read our latest Annual Report highlighting TROG achievements
Read our Q & A with TSC Chair A/Prof Hien Le
Get ready for World Radiotherapy Awareness Day 7 September

TROG 96.02 – Oesophagus

Completed
Gastrointestinal

Standard Radio-Chemotherapy for Oesophageal Cancer Patients

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)
Prev Post

TROG 96.03 – Accelerated Radiotherapy Oesophagus

Next Post

TROG 96.01 – Prostate – Androgen Deprivation

Related Post

29 July, 2025

TROG 21.07 SOCRATES HCC Trial Expands Outreach

TRIAL IN FOCUS: 29 July 2025 We’ve extended the

29 July, 2025

Major milestone for BIG 3-07/TROG 07.01 DCIS Study

TRIAL UPDATE: 29 July 2025 A large international study

Register now

For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

Facebook-f X-twitter Youtube Instagram Bluesky Streamline Icon: https://streamlinehq.com Bluesky

Quick Links

Legalities

Latest News

Keep up to date with TROG news, subscribe to our community newsletter.

Subscribe

ABN:  45 132 672 292